Sphera Funds Management Ltd. recently announced the acquisition of new stake in Compugen Ltd (NASDAQ:CGEN). The institutional investor has increased its shareholding in the Healthcare company by 7.27% to 1.32 million shares with purchase of 89431.0 shares. This fresh investment now brings its stake to 1.49% valued currently at $0.87 million. In addition, Renaissance Technologies LLC raised its holdings by 55900.0 to 1.09 million shares.
Currently, there are 86.62M common shares owned by the public and among those 83.51M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Compugen Ltd are Delaware Healthcare Fund, Taylor Frigon Core Growth Fund, and Tachlit SAL. Delaware Healthcare Fund owns 0.85 million shares of the company’s stock, all valued at over $0.57 million. Taylor Frigon Core Growth Fund sold 40907.0 shares to see its total holdings shrink to 0.42 million shares valued at over $0.28 million and representing 0.47% of the shares outstanding. Tachlit SAL bought 3663.0 shares to bring its total holdings to over 0.16 million shares at a value of $0.11 million. Tachlit SAL now owns shares totaling to 0.18% of the shares outstanding.
However, the script later moved the day high at 2.4600, up 173.97%. The company’s stock has a 5-day price change of 161.13% and 96.08% over the past three months. CGEN shares are trading 179.45% year to date (YTD), with the 12-month market performance up to 147.77% higher. It has a 12-month low price of $0.53 and touched a high of $1.49 over the same period. CGEN has an average intraday trading volume of 183.28K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 174.80%, 177.55%, and 123.73% respectively.
Institutional ownership of Compugen Ltd (NASDAQ: CGEN) shares accounts for 14.82% of the company’s 86.62M shares outstanding. Mutual fund holders own 12.06%, while other institutional holders and individual stakeholders account for 2.73% and — respectively.
It has a market capitalization of $176.66M and a beta (3y monthly) value of 2.45. The earnings-per-share (ttm) stands at -$0.36. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.50% over the week and 9.88% over the month.
Analysts forecast that Compugen Ltd (CGEN) will achieve an EPS of -$0.01 for the current quarter, -$0.12 for the next quarter and -$0.52 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.03 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was -$0.04 a year ago. Earnings per share for the fiscal year are expected to increase by 25.64%, and -17.24% over the next financial year.
Looking at the support for the CGEN, a number of firms have released research notes about the stock. Jefferies stated their Hold rating for the stock in a research note on August 05, 2022, with the firm’s price target at $2.
